Dr. Jacob (Kobi) Richter, formerly Chief Technology Officer of Medinol, led multiple departments including R&D, Manufacturing, Quality Control, and Regulatory Affairs. Before founding Medinol in 1992, he co-founded Orbotech and held key roles in product development and marketing. Additionally, he contributed to MIT's Artificial Intelligence Laboratory and Brain Research Department and served in Israeli Air Force R&D. Dr. Richter, with a Ph.D. in Physiology and Pharmacology from Tel Aviv University, is actively engaged in medical and brain research advisory roles. His investment in Quris reflects his commitment to innovative approaches like AI-driven 'patient on a chip' for enhancing drug development and reducing animal testing.